Tenon Medical, Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory
Tenon Medical, Inc. (TNON) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory of $61.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Asset Acquired, Asset › Business Combination, Recognized Asset Acquired, Asset, Current
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory · last filed 2026-03-27
- 2025-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory $61.00K.
- 2025-09-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory $61.00K.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory |
|---|---|
| 2025-12-31 | $61.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $61.00K 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |